RA Capital Management - VAXCYTE INC ownership

VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 76 filers reported holding VAXCYTE INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
RA Capital Management ownership history of VAXCYTE INC
ValueSharesWeighting
Q3 2023$402,296,129
+2.1%
7,891,2540.0%7.92%
+6.4%
Q2 2023$394,089,225
+44.2%
7,891,254
+8.2%
7.44%
+20.3%
Q1 2023$273,276,200
-2.7%
7,291,254
+24.5%
6.19%
+8.6%
Q4 2022$280,865,159
+155.5%
5,857,459
+27.9%
5.70%
+142.8%
Q3 2022$109,949,000
+10.3%
4,581,2030.0%2.35%
-11.7%
Q2 2022$99,687,000
-9.9%
4,581,2030.0%2.66%
+10.1%
Q1 2022$110,636,000
+9.7%
4,581,203
+8.0%
2.41%
+35.7%
Q4 2021$100,881,000
+2.0%
4,240,464
+8.8%
1.78%
+29.9%
Q3 2021$98,863,000
+13.6%
3,896,865
+0.8%
1.37%
-1.9%
Q2 2021$87,019,000
+14.0%
3,865,8080.0%1.40%
+21.4%
Q1 2021$76,350,000
-22.6%
3,865,808
+4.2%
1.15%
-16.5%
Q4 2020$98,593,000
-62.2%
3,710,699
-29.8%
1.38%
-71.1%
Q3 2020$260,915,000
+50.4%
5,283,818
-3.7%
4.77%
+41.1%
Q2 2020$173,513,0005,489,1813.38%
Other shareholders
VAXCYTE INC shareholders Q1 2021
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 1,049,893$53,523,54517.09%
Pivotal bioVenture Partners Investment Advisor LLC 793,036$40,429,12816.12%
Kynam Capital Management, LP 1,302,407$66,396,70910.86%
RA Capital Management 7,891,254$402,296,1297.92%
COMMODORE CAPITAL LP 1,100,000$56,078,0006.56%
GREAT POINT PARTNERS LLC 531,211$27,081,1374.93%
ACUTA CAPITAL PARTNERS, LLC 121,022$6,169,7024.14%
Frazier Life Sciences Management, L.P. 1,164,405$59,361,3673.94%
Novo Holdings A/S 845,000$43,078,1003.18%
BRAIDWELL LP 1,619,553$82,564,8122.61%
View complete list of VAXCYTE INC shareholders